Genes and Diseases (Sep 2024)

The landscape of epigenetic regulation and therapeutic application of N6-methyladenosine modifications in non-coding RNAs

  • Gui-e Xu,
  • Xuan Zhao,
  • Guoping Li,
  • Priyanka Gokulnath,
  • Lijun Wang,
  • Junjie Xiao

Journal volume & issue
Vol. 11, no. 5
p. 101045

Abstract

Read online

RNA N6-methyladenosine (m6A) methylation is the most abundant and conserved RNA modification in eukaryotes. It participates in the regulation of RNA metabolism and various pathophysiological processes. Non-coding RNAs (ncRNAs) are defined as small or long transcripts which do not encode proteins and display numerous biological regulatory functions. Similar to mRNAs, m6A deposition is observed in ncRNAs. Studying RNA m6A modifications on ncRNAs is of great importance specifically to deepen our understanding of their biological roles and clinical implications. In this review, we summarized the recent research findings regarding the mutual regulation between RNA m6A modification and ncRNAs (with a specific focus on microRNAs, long non-coding RNAs, and circular RNAs) and their functions. We also discussed the challenges of m6A-containing ncRNAs and RNA m6A as therapeutic targets in human diseases and their future perspective in translational roles.

Keywords